Publications by authors named "John Zalcberg"

100Publications

The short to medium term benefits of the Australian colorectal cancer screening program.

Med J Aust 2020 Nov 23. Epub 2020 Nov 23.

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja2.50859DOI Listing
November 2020

The acceleration of ageing in older patients with cancer.

J Geriatr Oncol 2020 Sep 12. Epub 2020 Sep 12.

School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Medical Oncology, The Alfred Hospital, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2020.09.010DOI Listing
September 2020

Cancer history and risk factors in healthy older people enrolling in the ASPREE clinical trial.

Contemp Clin Trials 2020 Sep 31;96:106095. Epub 2020 Jul 31.

Department of Epidemiology & Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, Victoria 3004, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2020.106095DOI Listing
September 2020

Developing an Australian multi-module clinical quality registry for gynaecological cancers: a protocol paper.

BMJ Open 2020 02 27;10(2):e034579. Epub 2020 Feb 27.

Gynaecological Oncology, Obstetrics and Gynaecology Clinical Institute, Epworth, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2019-034579DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050311PMC
February 2020

Comment on: 'Hospital lung surgery volume and patient outcomes'.

Lung Cancer 2020 04 3;142:138-139. Epub 2020 Jan 3.

Department of Respiratory Medicine, The Alfred Hospital, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2020.01.002DOI Listing
April 2020

Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib.

Future Oncol 2020 Jan 22;16(1):4251-4264. Epub 2019 Nov 22.

Portland VA Health Care System & OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0633DOI Listing
January 2020

Challenges of international oncology trial collaboration-a call to action.

Br J Cancer 2019 10 5;121(7):515-521. Epub 2019 Aug 5.

Alfred Health and the School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0532-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889481PMC
October 2019

Peeling the Onion of Health Care Disparity in Lung Cancer.

J Thorac Oncol 2019 08;14(8):e167-e168

Department of Preventive Medicine, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.03.026DOI Listing
August 2019

FDG-PET Follow-up of Non-Small Cell Lung Cancer: Not Dead Yet.

Ann Thorac Surg 2020 05 6;109(5):1624. Epub 2019 Jul 6.

Department of Epidemiology and Preventive Medicine, Monash University, 553 St. Kilda Rd, Melbourne, Victoria 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2019.05.042DOI Listing
May 2020

Seven electrocardiographs for seven clinical research studies.

Authors:
John R Zalcberg

BMJ 2019 04 17;365:l1720. Epub 2019 Apr 17.

Department of Medical Oncology, Alfred Health and School of Public Health, Monash University, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.l1720DOI Listing
April 2019

The value of participating in clinical trials: the whole is greater than the sum of its parts.

Med J Aust 2018 11;209(10):424-425

Prince of Wales Hospital, Sydney, NSW.

View Article

Download full-text PDF

Source
November 2018

Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM™ system in a quaternary oncology centre.

Cancer Chemother Pharmacol 2018 11 3;82(5):865-876. Epub 2018 Sep 3.

Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-018-3679-4
Publisher Site
http://dx.doi.org/10.1007/s00280-018-3679-4DOI Listing
November 2018

Rationale, Opportunities, and Reality of Biosimilar Medications.

Authors:
John R Zalcberg

N Engl J Med 2018 08;379(7):694

Monash University, Melbourne, VIC, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1808348DOI Listing
August 2018

Potential solutions to improve the governance of multicentre health services research.

Med J Aust 2018 08;209(4):187

Monash University, Melbourne, VIC.

View Article

Download full-text PDF

Source
August 2018

Biosimilars are coming: ready or not.

Authors:
John Zalcberg

Intern Med J 2018 09;48(9):1027-1034

Cancer Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/imj.14033
Publisher Site
http://dx.doi.org/10.1111/imj.14033DOI Listing
September 2018

Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?

J Natl Cancer Inst 2018 03;110(3):232-240

Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Hasselt University, Diepenbeek, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx179DOI Listing
March 2018

"Mind the Gap" Revisited.

Semin Oncol 2017 10 2;44(5):372-373. Epub 2017 Aug 2.

Head, Cancer Research Program, School of Public Health & Preventive Medicine Monash University, Melbourne, Australia; CEO, Wonder Drug Consulting Pty Ltd, Cronulla, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2017.07.003DOI Listing
October 2017

Towards a strategy for clinical quality registries in Australia.

Aust Health Rev 2019 Jul;43(3):284-287

School of Public Health and Preventive Medicine, Monash University, 553St Kilda Road, Melbourne, Vic. 3004, Australia. Email: ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1071/AH17201DOI Listing
July 2019

Telehealth

N Engl J Med 2018 01;378(4):402

Monash University, Melbourne, VIC, Australia

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1715239DOI Listing
January 2018

Exploring patient-reported outcomes following percutaneous coronary intervention: A qualitative study.

Health Expect 2018 04 12;21(2):457-465. Epub 2017 Nov 12.

Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Vic, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hex.12636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867323PMC
April 2018

Do all services provided as part of a clinical trial require research ethics and governance review?

Intern Med J 2017 Oct;47(10):1197-1199

School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imj.13565DOI Listing
October 2017

Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity.

Clin Genitourin Cancer 2017 10 8;15(5):e827-e834. Epub 2017 Jun 8.

South Australian Prostate Cancer Clinical Outcomes Collaborative, Adelaide, Australia; Freemasons Foundation Centre for Men's Health, University of Adelaide, Adelaide, Australia; Flinders Centre for Innovation in Cancer, Adelaide, Australia; Centre for Population Health Research, University of South Australia, Adelaide, Australia; Discipline of Surgery, University of Adelaide, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.06.001DOI Listing
October 2017

Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity.

Clin Genitourin Cancer 2017 12 30;15(6):629-634.e8. Epub 2017 Mar 30.

South Australian Prostate Cancer Clinical Outcomes Collaborative, Adelaide, SA, Australia; Freemasons Foundation Centre for Men's Health, University of Adelaide, Adelaide, SA, Australia; Flinders Centre for Innovation in Cancer, Adelaide, SA, Australia; Centre for Population Health Research, University of South Australia, Adelaide, SA, Australia; Discipline of Surgery, University of Adelaide, Adelaide, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.03.011DOI Listing
December 2017

Patient-Reported Outcomes After Radiation Therapy in Men With Prostate Cancer: A Systematic Review of Prognostic Tool Accuracy and Validity.

Int J Radiat Oncol Biol Phys 2017 06 21;98(2):318-337. Epub 2017 Feb 21.

South Australian Prostate Cancer Clinical Outcomes Collaborative; Freemasons Foundation Centre for Men's Health, University of Adelaide; Flinders Centre for Innovation in Cancer; Centre for Population Health Research, University of South Australia; Discipline of Surgery, University of Adelaide.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.02.024DOI Listing
June 2017

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.

J Clin Oncol 2017 May 31;35(15):1713-1720. Epub 2017 Mar 31.

Paolo G. Casali, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori and University of Milan; Elena Fumagalli and Alessandro Gronchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale Tumori, Milano, Italy; John Zalcberg, Peter MacCallum Cancer Institute, East Melbourne, Victoria; Dusan Kotasek, Adelaide Cancer Centre, Kurralta Park and University of Adelaide, South Australia, Australia; Axel Le Cesne, Gustave Roussy, Villejuif; Jean-Yves Blay, NetSARC and Site de Recherche Intégrée sur le Cancer de Lyon, Centre Leon Berard, Lyon; Antoine Italiano, Institut Bergonie, Bordeaux, France; Peter Reichardt, HELIOS Klinikum Berlin-Buch, Berlin; Lars H. Lindner, Klinikum der Universitaet München, München; Viktor Grünwald, School Hannover, Hannover, Germany; Ian R. Judson and Winette van der Graaf, Royal Marsden Hospital, London, United Kingdom; Patrick Schöffski, Universitaire Ziekenhuizen Leuven, Campus Gasthuisberg, Leuven; Saskia Litière and Sandrine Marreaud, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Serge Leyvraz, University Hospital, Lausanne, Switzerland; Antonio Lopez Pousa, Hospital De La Santa Creu I Sant Pau, Barcelona, Spain; Stefan Sleijfer and Jaap Verweij, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam; Jan M. Kerst, The Netherlands Cancer Institute, Amsterdam; Pancras Hogendoorn, Leiden University Medical Center, Leiden; Winette van der Graaf, Radboud University, Medical Center Nijmegen, the Netherlands; and Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.0228
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.0228DOI Listing
May 2017

Music's Relevance for People Affected by Cancer: A Meta-Ethnography and Implications for Music Therapists.

J Music Ther 2016 8;53(4):398-429. Epub 2016 Nov 8.

Caritas Christi Hospice and Department of Medicine, St Vincent's Hospital, The University of Melbourne and Cabrini Health, Melbourne.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jmt/thw013DOI Listing
February 2017

Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.

J Clin Oncol 2016 08 20;34(23):2728-35. Epub 2016 Jun 20.

Nick Pavlakis, Niall C. Tebbutt, Lara R. Lipton, John R. Zalcberg, John Simes, and David Goldstein, Australasian Gastro-Intestinal Trials Group; Nick Pavlakis, Royal North Shore Hospital, University of Sydney; Katrin M. Sjoquist, Andrew J. Martin, Eric Tsobanis, Sonia Yip, and John Simes, National Health and Medical Research Council Clinical Trials Centre, University of Sydney; Katrin M. Sjoquist, Cancer Care Centre, St George Hospital; Sonia Yip, Sydney Catalyst Translational Cancer Research Centre; Mark Wong, Westmead Hospital; David Goldstein, Prince of Wales Hospital, Sydney, New South Wales; Niall C. Tebbutt, Austin Health; Lara R. Lipton, Western Health; Andrew Strickland, Monash Medical Centre; John R. Zalcberg, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Yoon-Koo Kang, Asan Medical Center, University of Ulsan College of Medicine; Yung-Jue Bang, Seoul National University Hospital; Sun Young Rha, Yonsei University College of Medicine; Jeeyun Lee, Samsung Medical Center, Sungkyunkwan University School of Medicine; Jae-Yong Cho, Gangnam Severance Cancer Hospital, Yonsei University College of Medicine, Seoul; Jin Won Kim, Seoul National University Bundang Hospital, Seongnam, South Korea; Thierry Alcindor, McGill University Health Centre, Montreal, Quebec; Christopher J. O'Callaghan, National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario; and Margot J. Burnell, Saint John Regional Hospital, Saint John, New Brunswick, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019744PMC
August 2016

Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.

Clin Cancer Res 2016 05;22(10):2435-44

Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia. Translational Genomics and Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia. School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0414DOI Listing
May 2016

Serious adverse event reporting in investigator-initiated clinical trials.

Med J Aust 2016 Apr;204(6):231-3

Monash University, Melbourne, VIC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja15.01007DOI Listing
April 2016

Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset.

BMC Res Notes 2016 Jan 22;9:37. Epub 2016 Jan 22.

Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-016-1855-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724115PMC
January 2016

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.

J Clin Oncol 2015 Dec 16;33(36):4276-83. Epub 2015 Nov 16.

Paolo G. Casali, Elena Fumagalli, and Alessandro Gronchi, Fondazione Istituto di Recovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milano; Angelo P. Dei Tos, Azienda Unità Locale Socio Sanitaria 9 Treviso, Treviso, Italy; Axel Le Cesne, Gustave Roussy, Villejuif; Antoine Italiano, Institut Bergonie, Bordeaux; Antoine Adenis, Centre Oscar Lambret, Lille; Florence Duffaud, Hôpital de La Timone, Aix-Marseille Université, Marseille; Jean-Yves Blay, Centre Leon Berard, Lyon, France; Andres Poveda Velasco, Instituto Valenciano de Oncologia, Valencia; Javier M. Broto, Hospital Universitari Son Espases, Palma de Mallorca, Spain; Dusan Kotasek, Adelaide Cancer Centre, Kurralta Park, and University of Adelaide, Adelaide, South Australia; David Goldstein, Prince of Wales Hospital, New South Wales, Sydney; John R. Zalcberg, Peter MacCallum Cancer Institute, East Melbourne, Victoria, Australia; Piotr Rutkowski, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland; Peter Hohenberger, Mannheim University Medical Center, Mannheim; Jörg T. Hartmann, Christian-Albrechts University, Kiel, Germany; Ian R. Judson, Royal Marsden Hospital; Winette T.A. van der Graaf, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom; Hans Gelderblom, Leiden University Medical Center, Leiden; Winette T.A. van der Graaf, Radboud University Medical Center, Nijmegen, the Netherlands; Saskia Litière, and Sandrine Marréaud, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/11/16/JCO.2015.62
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.62.4304
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4304DOI Listing
December 2015

Clinical utility of ramucirumab in advanced gastric cancer.

Biologics 2015 22;9:93-105. Epub 2015 Sep 22.

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
https://www.dovepress.com/clinical-utility-of-ramucirumab-in
Publisher Site
http://dx.doi.org/10.2147/BTT.S62777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589126PMC
October 2015

Advances in Molecular Pathology and Treatment of Periampullary Cancers.

Pancreas 2016 Jan;45(1):32-9

From the *NHMRC Clinical Trials Centre; †Department of Surgery, The Prince Charles Hospital, Brisbane; ‡Department of Surgery, Flinders Medical Centre; §Queen Elizabeth Hospital, Adelaide; ∥University of Adelaide, South Australia; ¶School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne; #Cancer Care Centre, Department of Medical Oncology, St George Hospital; **Department of Surgery, Bankstown Hospital; and ††Division of Surgery, University of Western Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000385DOI Listing
January 2016

An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer.

Expert Opin Investig Drugs 2015 27;24(10):1307-20. Epub 2015 Jul 27.

a 1 Peter MacCallum Cancer Centre, Department of Medical Oncology , Melbourne, Australia +613 9656 1111 ; +613 9656 1135 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2015.1070483DOI Listing
May 2016

Views of Australian Medical Oncologists Regarding the Use of Mismatch Repair Status to Assist Adjuvant Chemotherapy Recommendations for Patients With Early-Stage Colon Cancer.

Clin Colorectal Cancer 2015 Sep 1;14(3):192-7. Epub 2015 Apr 1.

Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15330028150003
Publisher Site
http://dx.doi.org/10.1016/j.clcc.2015.03.001DOI Listing
September 2015

Accepting risk in the acceleration of drug development for rare cancers.

Lancet Oncol 2015 Apr;16(4):e190-4

Oxford Uehiro Centre for Practical Ethics, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)71153-2DOI Listing
April 2015

Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib.

Eur J Cancer 2015 May 19;51(7):852-60. Epub 2015 Mar 19.

Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.02.015DOI Listing
May 2015

Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database.

J Clin Oncol 2015 Jan 10;33(1):22-8. Epub 2014 Nov 10.

Qian Shi, Axel Grothey, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Aimery de Gramont and Benoist Chibaudel, Hospital Saint Antoine; Christophe Tournigand, Université Paris Est Créteil, Paris; Jean-Yves Douillard, Institute of Cancer Research in Western, St Herblain, France; John Zalcberg, Monash University; Niall C. Tebbutt, Austin Health, Melbourne, Victoria, Australia; Hans-Joachim Schmoll, Martin-Luther University, Halle; Rainer Porschen, Klinikum Bremen-Ost, Bremen; Volker Heinemann, University of Munich, München; Carsten Bokemeyer, University Hospital, Hamburg-Eppendorf, Germany; Matthew T. Seymour, Cancer Research UK Clincal Center, Leeds; Richard Adams, Cardiff University, Cardiff, United Kingdom; Leonard Saltz, Memorial Sloan-Kettering Cancer Center, New York, NY; Richard M. Goldberg, Ohio State University, Columbus, OH; Cornelis J.A. Punt, Academic Medical Center, Amsterdam, the Netherlands; Paulo M. Hoff, Hospital Sírio-Libanês, Sao Paulo, Brazil; Joel Randolph Hecht and Fairooz F. Kabbinavar, University of California at Los Angeles, Los Angeles, CA; Herbert Hurwitz, Duke University, Durham, NC; Eduardo Díaz-Rubio, Hospital Clinico San Carlos, Madrid, Spain; Charles Fuchs, Dana-Farber Cancer Institute, Boston, MA; John Souglakos, University of Crete, Heraklion, Greece; Alfredo Falcone, University of Pisa, Pisa, Italy; Eric Van Cutsem, University Hospital Gasthuisberg, Leuven; and Marc Buyse, International Drug Development Institute, Louvain-la-Neuve, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.5887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482837PMC
January 2015

Gastric cancer: past progress and present challenges.

Gastric Cancer 2015 Apr 26;18(2):205-9. Epub 2014 Oct 26.

NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-014-0437-0DOI Listing
April 2015

Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy.

Ther Adv Med Oncol 2014 Sep;6(5):222-8

School of Public Health and Preventative Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834014544892DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206614PMC
September 2014

Broken doctor-patient relationships: why won't they listen?

Med J Aust 2014 Sep;201(6):347-9

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja13.11211DOI Listing
September 2014

Bespoke treatment: drivers beware!

Asia Pac J Clin Oncol 2014 Dec 25;10(4):378-80. Epub 2014 Aug 25.

Cancer Genetics and Genomics Laboratory, The University of Melbourne, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12265DOI Listing
December 2014

Controversies in the management of gastrointestinal stromal tumors.

Asia Pac J Clin Oncol 2014 Sep 27;10(3):216-27. Epub 2014 Mar 27.

Department of Medical Oncology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia; ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12187DOI Listing
September 2014

Sound continuing bonds with the deceased: the relevance of music, including preloss music therapy, for eight bereaved caregivers.

Death Stud 2013 Feb;37(2):101-25

Division of Cancer Medicine, The University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07481187.2011.617488DOI Listing
February 2013

"A quiet still voice that just touches": music's relevance for adults living with life-threatening cancer diagnoses.

Support Care Cancer 2014 Apr 28;22(4):1037-47. Epub 2013 Nov 28.

Caritas Christi Hospice, St. Vincent's Hospital, 104 Studley Park Road, Kew, Melbourne, Australia, 3101,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-013-2059-1DOI Listing
April 2014

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Clin Cancer Res 2014 Feb 11;20(3):744-53. Epub 2013 Nov 11.

Authors' Affiliation: Flinders University, Flinders Centre for Innovation in Cancer; Department of Medical Oncology, Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0606DOI Listing
February 2014

Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics.

Asia Pac J Clin Oncol 2014 Mar 12;10(1):38-52. Epub 2013 Aug 12.

Oncology Division, Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12112DOI Listing
March 2014

Registry of gastric cancer treatment evaluation (REGATE): II treatment practice.

Asia Pac J Clin Oncol 2013 Dec 5;9(4):373-80. Epub 2013 Aug 5.

Thoraco-abdominal Oncosurgical Department, Clinical Hospital of the President Administration, Moscow, Russia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12089DOI Listing
December 2013

A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer.

J Hematol Oncol 2013 Jan 4;6. Epub 2013 Jan 4.

Pharmacy Department, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria, 3002, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-8722-6-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549734PMC
January 2013

Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors.

Ther Adv Med Oncol 2012 Sep;4(5):255-70

Department of Cancer Medicine, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, VIC 3002 and Department of Pathology, University of Melbourne, Parkville, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834012450935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424497PMC
September 2012

Dose optimization of tyrosine kinase inhibitors to improve outcomes in GIST.

Asia Pac J Clin Oncol 2012 Mar 20;8(1):43-52. Epub 2012 Feb 20.

Division of Cancer Medicine, Peter MacCallum Cancer Centre and Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2011.01491.xDOI Listing
March 2012

Comparative effectiveness research--a proposal for a new NHMRC funding stream.

Authors:
John R Zalcberg

Med J Aust 2012 Jan;196(1):22-3

Division of Cancer Medicine, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5694/mja11.10036DOI Listing
January 2012

What constitutes a multidisciplinary team meeting?

Asia Pac J Clin Oncol 2011 Sep;7(3):317

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2011.01429.xDOI Listing
September 2011

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Lancet Oncol 2011 Jul 16;12(7):681-92. Epub 2011 Jun 16.

National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S147020451170142
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(11)70142-5DOI Listing
July 2011